BRIANNA PAESANO: Open Payments
NPI 1518522176 · STAMFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$66,115 in 291 payments from 22 companies in 2025. Trend: 2023 $39,304 · 2024 $17,032 · 2025 $66,115
Speaker / faculty: $55,200Travel & lodging: $6,251Food & beverage: $4,489Education: $175
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 159 | $63,589 |
| Janssen Biotech, Inc. | 22 | $535 |
| PFIZER INC. | 12 | $337 |
| Regeneron Healthcare Solutions, Inc. | 13 | $251 |
| ABBVIE INC. | 17 | $234 |
| GENZYME CORPORATION | 12 | $230 |
| Incyte Corporation | 20 | $219 |
| Galderma Laboratories, L.P. | 12 | $216 |
| UCB, Inc. | 4 | $68 |
| Journey Medical Corporation | 2 | $45 |
Products named: EBGLYSS, TREMFYA, DUPIXENT, CIBINQO, OPZELURA, NEMLUVIO, SKYRIZI, RINVOQ.
Industry payments across CT — which companies pay providers there.
